The Brighton Collaboration Setting Standards in Vaccine Safety 
About us Structure Process Working Groups Definitions & Guidelines Communications News
Your location: Home » Working Groups  
Working Groups
Working Group Member Selection and Process
Reference Groups


Working Groups



View Ongoing and Closed Working Groups

Download Published Case Definition & Guidelines Documents of the Working Groups


Status of Case Definitions and Guidelines of Working Groups
 
Topic Coordinators Member Selection Status of Document
  Initial draft In Revision Finalized
Document development started in 2008
1 Pain at Injection Site Jane Gidudu Local Reaction
2 Yellow Fever Mark Gershman Complete
Document development started in 2007
3 International Implementation Barbara Rath Complete
4 Bells Palsy Barbara Rath Complete
5 Diarrhea Jane Gidudu Complete
Document development started in 2006
Document development started in 2005
6 Guillain-Barré Syndrome James Sejvar, Katrin Kohl Complete
7 A Local Reaction Katrin Kohl, Jane Gidudu Local Reaction
Document development started in 2004
8 Neonatal Clinical Trials Guidelines Hans Spiegel, Katrin Kohl, Jane Gidudu Complete
9 Aseptic Meningitis Terhi Tapiainen Complete
Document development started in 2003
10 Anaphylaxis Jens Rueggeberg Complete
11 Encephalitis and Accute Disseminated Encephalomyelitis James Sejvar, Katrin Kohl Complete
12 Fatiguing Illness Including Chronic Fatigue Syndrome Jim Jones, Katrin Kohl Complete
13 Rash John Beigel, Katrin Kohl Complete
14 Thrombocytopenia Jan Bonhoeffer Complete
15 Sudden Unexplained Death Syndrome Including SIDS Terhi Tapiainen Complete
16 Vaccinia Virus AEFI Phil LaRussa, Phil Graham, Katrin Kohl Complete
  Eczema Vaccinatum Patricia Nell, Katrin Kohl Complete
  Generalized Vaccinia John Beigel, Katrin Kohl Complete
  Inadvertent Inoculation James Oleske, Katrin Kohl Complete
  Progressive Vaccinia Patricia Nell, Katrin Kohl Complete
  Robust Take Phil LaRussa, Katrin Kohl Complete
Document development started in 2002
17 Guidelines for Clinical Trials and Other Studies Jan Bonhoeffer Complete
18 General Guidelines for Surveillance Systems Jan Bonhoeffer Complete
19 Local Reactions Katrin Kohl Complete
  Abscess Leslie Ball, Katrin Kohl Complete
  Cellulitis Scott Halperin, Katrin Kohl Complete
  Induration Wikke Walop, Katrin Kohl Complete
  Swelling Wikke Walop, Katrin Kohl Complete
20 Persistent Crying Jan Bonhoeffer Complete
21 Generalized Convulsive Seizure Jan Bonhoeffer Complete
Document Development Started in 2001
22 Hypotonic-Hyporesponsive Episode Jan Bonhoeffer Complete
23 Fever Katrin Kohl Complete
24 Intussusception Katrin Kohl Complete
25 Nodule at Injection Site Katrin Kohl Local Reaction
Currently there are no draft definitions and guidelines open for for review and comment. However, if you would like to complete a web-based survey for any of the upcoming draft definitions, please e-mail: secretariat@brightoncollaboration.org.


The progress of the Working Groups is symbolized in the following way:

Initial draft: Development phase - A draft document is being developed within the respective Working Group

In revision: Comment and review phase - Comments are being received by Reference Group participants via web-based surveys and as appropriate also by the CIOMS/WHO Vaccine Pharmacovigilance Working Group and integrated by the respective Working Group into the document.

Finalized: Editing phase - Final drafts are being harmonized with other Brighton documents, submitted for clearance in the respective organizations of Working Group members, and prepared for submission to a journal.




Progress of Working Groups (last update): August 19, 2008
 
> back to top